Denali Therapeutics Inc. Quarterly Current Ratio in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Denali Therapeutics Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q3 2024.
  • Denali Therapeutics Inc. Current Ratio for the quarter ending September 30, 2024 was 1.19K %, a 110% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.19K +625 +110% Sep 30, 2024
Q2 2024 1.34K +915 +214% Jun 30, 2024
Q1 2024 1.46K +1.12K +333% Mar 31, 2024
Q4 2023 780 +454 +139% Dec 31, 2023
Q3 2023 566 +276 +95.2% Sep 30, 2023
Q2 2023 427 +65.5 +18.1% Jun 30, 2023
Q1 2023 338 -181 -34.8% Mar 31, 2023
Q4 2022 326 -551 -62.8% Dec 31, 2022
Q3 2022 290 -2.01K -87.4% Sep 30, 2022
Q2 2022 362 -1.49K -80.5% Jun 30, 2022
Q1 2022 519 -1.02K -66.2% Mar 31, 2022
Q4 2021 878 -404 -31.5% Dec 31, 2021
Q3 2021 2.3K +1.3K +130% Sep 30, 2021
Q2 2021 1.85K +797 +75.6% Jun 30, 2021
Q1 2021 1.54K +449 +41.2% Mar 31, 2021
Q4 2020 1.28K +226 +21.4% Dec 31, 2020
Q3 2020 999 -166 -14.2% Sep 30, 2020
Q2 2020 1.05K -152 -12.6% Jun 30, 2020
Q1 2020 1.09K -168 -13.4% Mar 31, 2020
Q4 2019 1.06K -382 -26.6% Dec 31, 2019
Q3 2019 1.16K -483 -29.3% Sep 30, 2019
Q2 2019 1.21K Jun 30, 2019
Q1 2019 1.26K Mar 31, 2019
Q4 2018 1.44K Dec 31, 2018
Q3 2018 1.65K Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.